Metabolic Disorders: Difference between revisions
Jump to navigation
Jump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:Acid beta glucosidase.png|350px|right|thumb| Acid Beta Glucosidase, a Major Target for Gaucher Disease]] | [[Image:Acid beta glucosidase.png|350px|right|thumb| Acid Beta Glucosidase, a Major Target for Gaucher Disease]] | ||
[[Metabolic Disorders]] broadly covers illnesses related to faulty carbohydrate metabolism, [[ | [[Metabolic Disorders]] broadly covers illnesses related to faulty carbohydrate metabolism, [[Amino Acid Metabolism]], organic acid metabolism, or lysosomal storage. | ||
Articles in Proteopedia concerning metabolic disorders include: | Articles in Proteopedia concerning metabolic disorders include: | ||
Revision as of 16:23, 25 September 2010
Metabolic Disorders broadly covers illnesses related to faulty carbohydrate metabolism, Amino Acid Metabolism, organic acid metabolism, or lysosomal storage.
Articles in Proteopedia concerning metabolic disorders include:
- Acid-beta-glucosidase
- ß-2 Microglobulin
- Protective Protein/Cathepsin A (PPCA)
- Protective Protein/Cathepsin A (PPCA) 2
- Treatment_of_Gaucher_disease
- Velaglucerase
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets